Global Radiofrequency Ablation Devices Market

Radiofrequency Ablation Devices Market Size, Share, Growth Analysis, By Type (Unipolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation), By Component Type (Disposable equipment, Capital equipment), By Application (Surgical oncology, Cardiology & cardiac rhythm management), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2903 | Region: Global | Published Date: November, 2024
Pages: 200 | Tables: 65 | Figures: 70

Radiofrequency Ablation Devices Market News

  • In January 2024, Boston Scientific Corporation stated that it received the U.S. FDA approval for its FARAPULSE™ Pulsed Field Ablation (PFA) System. The said device is an exceptional substitute to the regular SOC thermal ablation treatment and is dedicated for isolating pulmonary veins for treating drug, recurrent, refractory, paroxysmal atrial fibrillation (AF), and symptomatic.
  • In August 2023, Medtronic stated that its revised ClosureFast™ radiofrequency ablation (RFA) catheter (in low 6F profile) receive clearance from the U.S. FDA. The said procedure is dedicated to help cure CVI (chronic venous insufficiency), a progressive condition that impacts leg veins that returns blood to the heart.
  • In July 2024, Stryker introduced MultiGen 2 Radiofrequency (RF) Generator, which offers optimal efficiency, reliability, and control to the physicians that require while performing radiofrequency ablation.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Radiofrequency Ablation Devices Market size was valued at USD 4.34 Billion in 2022 and is poised to grow from USD 4.85 Billion in 2023 to USD 11.66 Billion by 2031, growing at a CAGR of 11.6% in the forecast period (2024-2031).

The global radiofrequency ablation devices market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Medtronic plc ', 'Boston Scientific Corporation ', 'Abbott Laboratories ', 'Johnson & Johnson ', 'Stryker Corporation ', 'Smith & Nephew plc ', 'Olympus Corporation ', 'Hologic, Inc. ', 'Merit Medical Systems, Inc. ', 'AngioDynamics, Inc. ', 'CryoLife, Inc. (Artivion, Inc.) ', 'AtriCure, Inc. ', 'ELIAS Medical ', 'Eppendorf AG ', 'Sientra, Inc. ', 'Neotract, Inc. ', 'Biotronik SE & Co. KG ', 'Ablative Solutions, Inc.'

The demand for minimally invasive procedures is significantly increasing owing to its benefits over conventional procedures, comprising less infection risk, short recovery times, and comparatively less postoperative pain. The globally increasing aging population is highly prone to conditions that need RFA treatment like chronic disease pain and tumors. The growing demographic inclination is fueling the market growth.

(PFA) Pulsed Field Ablation: Pulsed-field ablation has lately gained traction as a progressive technology for ablation. It makes use of large electrodes to decrease current density. This technology is for non-thermal ablation. Based on recent studies, myocardium is highly susceptible to the effects of PFA compared to other tissues, mainly the nerves and esophagus.

Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to well-developed healthcare infrastructure, especially in Canada and the United States that have easy access to technologically improved medical technologies like RFA devices. The regional growth is also impacted by growing cases of chronic diseases that demand efficient and safe radiofrequency ablation treatments and heavy investments in innovation and research and development. Also, favorable reimbursement policies and high healthcare spending is contributing to the adoption of improved medical devices like RFA devices. The prominent players operating in North America include AngioDynamics, Boston Scientific Corporation, Ethicon Inc., Medtronic, Philips, and more.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Radiofrequency Ablation Devices Market

Report ID: SQMIG35A2903

$5,300
BUY NOW GET FREE SAMPLE